Drug Price Transparency in Medicaid Act of 2023
Latest action · Mar 24, 2023 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 17, 2023
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Drug Price Transparency in Medicaid Act of 2023
This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions and survey participation to be made publicly available.
Cosponsors 37
Members who signed on, in the order they did. Signatures ran from Mar 17, 2023 to Sep 12, 2024; 5 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NC | Deborah K. Ross | Original | Mar 17, 2023 |
| R-NY | Elise M. Stefanik | Original | Mar 17, 2023 |
| D-MA | Jake Auchincloss | Original | Mar 17, 2023 |
| R-GA | Rick W. Allen | Original | Mar 17, 2023 |
| D-TX | Vicente Gonzalez | Original | Mar 17, 2023 |
| R-FL | Cory Mills | Mar 27, 2023 | |
| D-IL | Raja Krishnamoorthi | Apr 3, 2023 | |
| D-MD | David J. Trone | Apr 13, 2023 | |
| R-NY | Nicole Malliotakis | Apr 13, 2023 | |
| R-TX | Roger Williams | Apr 13, 2023 | |
| R-TN | Diana Harshbarger | Apr 17, 2023 | |
| R-NY | Nicholas A. Langworthy | Apr 18, 2023 | |
| D-CA | Scott H. Peters | Apr 18, 2023 | |
| R-IA | Mariannette Miller-Meeks | Apr 25, 2023 | |
| R-MD | Andy Harris | Apr 26, 2023 | |
| R-MO | Mark Alford | Apr 26, 2023 | |
| D-MI | Rashida Tlaib | Apr 26, 2023 | |
| R-PA | Glenn Thompson | Apr 27, 2023 | |
| D-GA | Sanford D. Bishop, Jr. | Apr 28, 2023 | |
| R-NE | Don Bacon | May 2, 2023 | |
| R-NY | Michael Lawler | May 5, 2023 | |
| R-KS | Tracey Mann | May 10, 2023 | |
| R-AL | Jerry L. Carl | May 16, 2023 | |
| R-FL | Neal P. Dunn | May 16, 2023 | |
| D-WA | Marie Gluesenkamp Perez | May 17, 2023 | |
| R-PA | Daniel Meuser | May 22, 2023 | |
| R-AL | Mike Rogers | May 22, 2023 | |
| D-NY | Patrick Ryan | May 24, 2023 | |
| R-LA | Garret Graves | Jun 6, 2023 | |
| R-NY | George Santos | Jul 14, 2023 | |
| R-OR | Cliff Bentz | Jul 20, 2023 | |
| R-NY | Nick LaLota | Aug 22, 2023 | |
| D-NY | Thomas R. Suozzi | Apr 17, 2024 | |
| D-PA | Matt Cartwright | Jun 18, 2024 | |
| R-NC | Chuck Edwards | Jun 21, 2024 | |
| D-IL | Nikki Budzinski | Aug 6, 2024 | |
| D-NY | Joseph D. Morelle | Sep 12, 2024 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Mar 17, 2023 |
| Health Subcommittee | Referred Mar 24, 2023 |
Actions 3
Everything that happened, newest first.
- Mar 24, 2023Referred to the Subcommittee on Health.
- Mar 17, 2023Introduced in House
- Mar 17, 2023Referred to the House Committee on Energy and Commerce.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Lists H1294–H1296H.R. 1613–1667 | — | Mar 17, 2023 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 50, March 17, 2023, page H1294.
Printed hearings 3
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 118-804 | RURAL HEALTH CARE: SUPPORTING LIVES AND IMPROVING COMMUNITIES240 pages | Finance Committee | May 16, 2024 |
| Serial No. 118-27 | LOWERING UNAFFORDABLE COSTS: LEGISLATIVE SOLUTIONS TO INCREASE TRANSPARENCY AND COMPETITION IN HEALTHCARE364 pages | Energy and Commerce Committee | Apr 26, 2023 |
| S. Hrg. 118-542 | PHARMACY BENEFIT MANAGERS AND THE PRESCRIPTION DRUG SUPPLY CHAIN: IMPACT ON PATIENTS AND TAXPAYERS280 pages | Finance Committee | Mar 30, 2023 |
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 1038 | Drug Price Transparency in Medicaid Act of 2023 | Identical bill | Mar 29, 2023 |
| HR 3561 | PATIENT Act of 2023 | Related bill | Dec 17, 2024 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program.
- Short Title(s) as Introduced
- Drug Price Transparency in Medicaid Act of 2023
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Business records
- Congressional oversight
- Government information and archives
- Health
- Health care costs and insurance
- Home and outpatient care
- Inflation and prices
- Medicaid
- Prescription drugs
- Public contracts and procurement
- Retail and wholesale trades
- State and local government operations
- User charges and fees
Text 1
Each version as it was printed, newest first.
- Mar 17, 2023Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
